Benjamin Reardon and Emmanuel J Favaloro/LinkedIn
Mar 16, 2026, 15:56
Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring
Emmanuel J. Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Latest publication from the Sydney Centres for Thrombosis and Haemostasis.
Heparin Anticoagulant Therapy and Its Monitoring.
Another review ably led by Benjamin Reardon.
Enjoy! ”
Title: Heparin Anticoagulant Therapy and Its Monitoring
Authors: Benjamin Reardon, Leonardo Pasalic, Giuseppe Lippi, Emmanuel J. Favaloro
Read the Full Article on Biomolecules.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 21, 2026, 19:19Tribikram Panda: Ensuring Global Equity in Management of Sickle Cell Disease
-
Jun 21, 2026, 19:15Vicken Babikian Receives Mkhitar Heratsi Medal – AAHPO
-
Jun 21, 2026, 19:11Joaqim Meireles-Brandao: Once Disease is Established, All That Remains is to Mitigate the Consequences
-
Jun 21, 2026, 18:54A Comprehensive Review of Hemophilia A and B – Journal of Thrombosis and Haemostasis
-
Jun 21, 2026, 18:54Maxime Dely: Raising Awareness and Improving Diagnosis of Sickle Cell Disease in France
-
Jun 21, 2026, 18:08Roberta Gualtierotti: Point-of-Care SPR Device for Rapid Detection of Anti-PEG Antibodies
-
Jun 21, 2026, 17:59Fakhrul Abedin Jon: Exploring Types of Brain Bleeding
-
Jun 21, 2026, 17:00Jeffrey Schnur: Advanced Treatment Strategies for Deep Vein Thrombosis and Pulmonary Embolism
-
Jun 21, 2026, 16:53Matteo Foschi: When Should We Restart Anticoagulation After a Breakthrough Ischemic Stroke?